← Back to Bills
H.R. 7658House117th Congress (2021-2023)In Committee

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Sponsored by Tom O'HalleranRep. Tom O'Halleran (D-AZ)
Introduced May 3, 2022

AI-Generated Summary

Updated February 8, 2026 at 11:07 AM UTC

The bill amends the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public‑Private Partnerships program. It updates the authorized funding level, setting a budget of $10 million per year for fiscal years 2023 through 2027, replacing the previous $6 million per year allocation for 2018‑2022. The change affects the program’s funding and its ability to support collaborative efforts to advance medical product development.

Key Provisions

  • Changes the authorized funding for the Critical Path Public‑Private Partnerships from $6 million per year (FY 2018‑2022) to $10 million per year (FY 2023‑2027).

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
HouseIntro Referral Latest Action

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

May 3, 2022

View full timeline
HouseIntro Referral

Introduced in House

May 3, 2022

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

May 3, 2022

Bill Text

Latest available legislative text

Reading Mode
Latest
Raw Text PDF XML
Introduced in HouseIssued May 3, 2022

I

117th CONGRESS

2d Session

H. R. 7658

IN THE HOUSE OF REPRESENTATIVES

May 3, 2022

Mr. O'Halleran (for himself and Mrs. Lesko) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

1.

Reauthorization of the Critical Path Public-Private Partnerships

Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–5(f)) is amended by striking $6,000,000 for each of fiscal years 2018 through 2022 and inserting $10,000,000 for each of fiscal years 2023 through 2027.